ArticleHuman vaccines & immunotherapeutics2022

Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants.

Zhuoming Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.